These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18633587)

  • 1. [Zonisamide as add-on treatment for focal epilepsies. An outcome analysis of 74 patients].
    Wellmer S; Wellmer J; Bauer J
    Nervenarzt; 2008 Dec; 79(12):1416, 1418-23. PubMed ID: 18633587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: Experiences from two tertiary epilepsy centers.
    Doğan EA; Genç E; Genç BO; Erdoğan Ç
    Epilepsy Behav; 2017 Nov; 76():19-23. PubMed ID: 28927711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures.
    Faught E; Ayala R; Montouris GG; Leppik IE;
    Neurology; 2001 Nov; 57(10):1774-9. PubMed ID: 11723262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients.
    Heo K; Lee BI; Yi SD; Cho YW; Shin DJ; Song HK; Kim OJ; Park SP; Kim SE; Kim SH; Lee JH; Kim KS; Lee SJ
    Seizure; 2012 Apr; 21(3):188-93. PubMed ID: 22226572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention rate of zonisamide in intractable epilepsy.
    Nakken KO; Lindstrøm P; Andersen H
    Acta Neurol Scand; 2015 May; 131(5):268-74. PubMed ID: 25644477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticonvulsant treatment with zonisamide added to topiramate. A preliminary treatment analysis in 19 patients].
    Bös M; Bauer J
    Nervenarzt; 2007 Dec; 78(12):1425-9. PubMed ID: 17898981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
    Janszky J; Horvath R; Komoly S
    Ideggyogy Sz; 2015 May; 68(5-6):149-53. PubMed ID: 26182605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy.
    Mandelbaum DE; Bunch M; Kugler SL; Venkatasubramanian A; Wollack JB
    J Child Neurol; 2005 Jul; 20(7):594-7. PubMed ID: 16159527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and long-term efficacy of zonisamide as adjunctive therapy for focal epilepsy.
    Schulze-Bonhage A
    Expert Rev Neurother; 2015; 15(8):857-65. PubMed ID: 26144543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with partial-onset seizures under adjunctive therapy with zonisamide: results from a prospective non-interventional surveillance study.
    Helmstaedter C; Stefan H; Witt JA
    Epileptic Disord; 2011 Sep; 13(3):263-76. PubMed ID: 21914589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and monitoring of patients treated with zonisamide: the OZONE study.
    Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B
    Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.